There are 122 resources available
Closing Remarks
Presenter: Enrique Grande
Session: Merck Healthcare KGaA - Sequencing is Key: Unlocking Individualized Treatment in Bladder Cancer
Resources:
Webcast
Chair Welcome and Introductions
Presenter: Howard Hochster
Session: Takeda - Navigating Later-Line Metastatic Colorectal Cancer: The Latest Data Guiding Treatment Selection and Sequencing
Resources:
Webcast
Welcome and Introduction
Presenter: Benjamin Besse
Session: AbbVie Inc. - Targeting un-MET Needs in Cancer: The Emerging Role of Antibody-Drug Conjugates (ADCs)
Resources:
Webcast
Navigating Complexities in Patient Cases: What’s Your Next Treatment for Refractory Disease?
Presenter: Sebastian Stintzing
Session: Takeda - Navigating Later-Line Metastatic Colorectal Cancer: The Latest Data Guiding Treatment Selection and Sequencing
Resources:
Webcast
History of c-Met: Lessons Learned
Presenter: Benjamin Besse
Session: AbbVie Inc. - Targeting un-MET Needs in Cancer: The Emerging Role of Antibody-Drug Conjugates (ADCs)
Resources:
Webcast
Treatment Options in Refractory mCRC
Presenter: Rocio Garcia-Carbonero
Session: Takeda - Navigating Later-Line Metastatic Colorectal Cancer: The Latest Data Guiding Treatment Selection and Sequencing
Resources:
Webcast
Rethinking c-Met as a Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)
Presenter: Antonio Passaro
Session: AbbVie Inc. - Targeting un-MET Needs in Cancer: The Emerging Role of Antibody-Drug Conjugates (ADCs)
Resources:
Webcast
Factors Impacting Treatment Choice in Refractory Setting
Presenter: Howard Hochster
Session: Takeda - Navigating Later-Line Metastatic Colorectal Cancer: The Latest Data Guiding Treatment Selection and Sequencing
Resources:
Webcast
Targeting c-Met in Advanced NSCLC with ADCs
Presenter: Nicolas Girard
Session: AbbVie Inc. - Targeting un-MET Needs in Cancer: The Emerging Role of Antibody-Drug Conjugates (ADCs)
Resources:
Webcast
Live Panel Q&A Session
Presenter: Howard Hochster, Sebastian Stintzing, Rocio Garcia-Carbonero
Session: Takeda - Navigating Later-Line Metastatic Colorectal Cancer: The Latest Data Guiding Treatment Selection and Sequencing
Resources:
Webcast